NEO
#1904
NeoGenomics, Inc. - Common Stock
18.0 5 USD
-0.03%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-3.17%
Monthly Change
+14.39%
6 month change
+87.24%
Year Change
+106.29%
Previous Close
18.6 4
Open
18.0 5
Low
18.0 5
High
18.0 5
Volume
101
Financials
- Market Capitalization 2.32 B
- Employee 2 500
- Founded 2002
- CEO Christopher M. Smith
- Website www.neogenomics.com
- Headquarter Nevada, United States
- FIGI BBG000BKH263
- Industry Diagnostics & Research
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-13.95
Price to sales ratio
2.07
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1832 |  CDNA CareDx, Inc. - Common Stock | 49.79 USD | -4.91% | +3.08% | +17.24% | +233.94% | 2.58 B USD | ||
| 1840 |  NEOG Neogen Corporation - Common Stock | 11.66 USD | -0.68% | -2.26% | -0.93% | +104.56% | 2.54 B USD | ||
| 2069 |  PSNL Personalis, Inc. - Common Stock | 17.07 USD | +1.61% | +0.29% | +33.88% | +255.63% | 1.82 B USD | ||
| 2401 |  OPK Opko Health, Inc. - Common Stock | 1.48 USD | -1.33% | -0.67% | +11.28% | +8.82% | 1.10 B USD |
Frequently asked questions about NeoGenomics, Inc.
What is the NeoGenomics, Inc. stock price today?
The current price of NeoGenomics, Inc. (NEO) is 18.05. Over the past 24 hours, the stock has changed by -3.17%. Follow the NEO chart for real-time price dynamics.
What is the stock ticker of NeoGenomics, Inc.?
NeoGenomics, Inc. trades under the ticker NEO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is NeoGenomics, Inc. stock going up?
NEO has changed by +7.76% over the last week, +14.39% over the last month, and +106.29% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of NeoGenomics, Inc.?
NeoGenomics, Inc. currently has a market capitalization of 2.32 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were NeoGenomics, Inc. earnings last quarter?
Last quarter, NeoGenomics, Inc. reported earnings of 0.02 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was NeoGenomics, Inc. revenue for the last quarter?
NeoGenomics, Inc. reported quarterly revenue of 201.66 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was NeoGenomics, Inc. net income for the last quarter?
NeoGenomics, Inc. reported net income of 2.24 M for the last quarter. The previous quarter showed -17.11 M, which means net income changed by +113.08%.
How many employees does NeoGenomics, Inc. have?
As of the latest available data, NeoGenomics, Inc. has 2 500 employees. Workforce size can provide additional context about the company's scale and operations.
What is NeoGenomics, Inc. EBITDA?
NeoGenomics, Inc. EBITDA is -5.16 M, and its EBITDA margin is -2.56%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy NeoGenomics, Inc. stock?
You can buy NeoGenomics, Inc. (NEO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in NeoGenomics, Inc. stock?
Investing in NeoGenomics, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NEO chart and related analysis on metatrader.com as part of your research.